These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 2374145)

  • 1. Brain targeting of anti-HIV nucleosides: synthesis and in vitro and in vivo studies of dihydropyridine derivatives of 3'-azido-2',3'-dideoxyuridine and 3'-azido-3'-deoxythymidine.
    Chu CK; Bhadti VS; Doshi KJ; Etse JT; Gallo JM; Boudinot FD; Schinazi RF
    J Med Chem; 1990 Aug; 33(8):2188-92. PubMed ID: 2374145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid pharmacokinetic models to describe anti-HIV nucleoside brain disposition following parent and prodrug administration in mice.
    Gallo JM; Etse JT; Doshi KJ; Boudinot FD; Chu CK
    Pharm Res; 1991 Feb; 8(2):247-53. PubMed ID: 2023876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3'-Azido-2',3'-dideoxyuridine (AzddU): comparative pharmacokinetics with 3'-azido-3'-deoxythymidine (AZT) in monkeys.
    Boudinot FD; Schinazi RF; Gallo JM; McClure HM; Anderson DC; Doshi KJ; Kambhampathi PC; Chu CK
    AIDS Res Hum Retroviruses; 1990 Feb; 6(2):219-28. PubMed ID: 2328158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacokinetics of 3'-azido-3'-deoxythymidine (AZT) and 3'-azido-2',3'-dideoxyuridine (AZddU) in mice.
    Doshi KJ; Gallo JM; Boudinot FD; Schinazi RF; Chu CK
    Drug Metab Dispos; 1989; 17(6):590-4. PubMed ID: 2575492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic evaluation of 3'-azido-2', 3'-dideoxyuridine-5'-O-valinate-hydrochloride as a prodrug of the anti-HIV nucleoside 3'-azido-2', 3'-dideoxyuridine.
    Kong L; Cooperwood JS; Huang SH; Chu CK; Boudinot FD
    Antivir Chem Chemother; 2003 Sep; 14(5):263-70. PubMed ID: 14694989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, in vitro biological stability, and anti-HIV activity of 5-halo-6-alkoxy(or azido)-5,6-dihydro-3'-azido-3'-deoxythymidine diastereomers as potential prodrugs to 3'-azido-3'-deoxythymidine (AZT).
    Kumar R; Wang L; Wiebe LI; Knaus EE
    J Med Chem; 1994 Dec; 37(25):4297-306. PubMed ID: 7996541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo biodistribution, pharmacokinetic parameters, and brain uptake of 5-halo-y-methoxy(or ethoxy)-5,6-dihydro-3'-azido-3'-deoxythymidine diastereomers as potential prodrugs of 3'-azido-3'-deoxythymidine.
    Wang L; Morin KW; Kumar R; Cheraghali M; Todd KG; Baker GB; Knaus EE; Wiebe LI
    J Med Chem; 1996 Feb; 39(4):826-33. PubMed ID: 8632406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphatic distribution of 3'-azido-3'-deoxythymidine and 3'-azido-2',3'-dideoxyuridine in mice.
    Manouilov KK; White CA; Boudinot FD; Fedorov II; Chu CK
    Drug Metab Dispos; 1995 Jun; 23(6):655-8. PubMed ID: 7587948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, in vitro and in vivo release kinetics, and anti-HIV activity of a sustained-release prodrug (mPEG-AZT) of 3'-azido-3'-deoxythymidine (AZT, Zidovudine).
    Li W; Chang Y; Zhan P; Zhang N; Liu X; Pannecouque C; De Clercq E
    ChemMedChem; 2010 Nov; 5(11):1893-8. PubMed ID: 20936623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, in vitro anti-human immunodeficiency virus structure-activity relationships and biological stability of 5'-O-myristoyl analogue derivatives of 3'-azido-2',3'-dideoxythymidine (AZT) as potential prodrugs.
    Parang K; Wiebe LI; Knaus EE
    Antivir Chem Chemother; 1998 Jul; 9(4):311-23. PubMed ID: 9875410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and tissue distribution of (+/-)-3'-azido-2',3'-dideoxy-5'-O-(2-bromomyristoyl)thymidine, a prodrug of 3'-azido-2',3'-dideoxythymidine (AZT) in mice.
    Parang K; Wiebe LI; Knaus EE
    J Pharm Pharmacol; 1998 Sep; 50(9):989-96. PubMed ID: 9811159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and anti-HIV activity of steroidal prodrugs of 3'-azido-3'-deoxythymidine (AZT).
    Balagopala MI; Ollapally AP; Lee HJ
    Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S1-7. PubMed ID: 8574137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AIDS dementia: synthesis and properties of a derivative of 3'-azido-3'-deoxythymidine (AZT) that may become 'locked' in the central nervous system.
    Torrence PF; Kinjo J; Lesiak K; Balzarini J; De Clercq E
    FEBS Lett; 1988 Jul; 234(1):135-40. PubMed ID: 3164686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain, blood, and cerebrospinal fluid distribution of a zidovudine chemical delivery system in rabbits.
    Brewster ME; Anderson W; Bodor N
    J Pharm Sci; 1991 Sep; 80(9):843-6. PubMed ID: 1800706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro evaluation of some modified 4-thiopyrimidine nucleosides for prevention or reversal of AIDS-associated neurological disorders.
    Palomino E; Meltsner BR; Kessel D; Horwitz JP
    J Med Chem; 1990 Jan; 33(1):258-63. PubMed ID: 2153206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular metabolism and pharmacokinetics of 5'-hydrogenphosphonate of 3'-azido-2',3'-dideoxythymidine, a prodrug of 3'-azido-2',3'-dideoxythymidine.
    Skoblov Y; Karpenko I; Shirokova E; Popov K; Andronova V; Galegov G; Kukhanova M
    Antiviral Res; 2004 Aug; 63(2):107-13. PubMed ID: 15302139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo pharmacokinetic characterization of two novel prodrugs of zidovudine.
    Quevedo MA; Briñón MC
    Antiviral Res; 2009 Aug; 83(2):103-11. PubMed ID: 19549583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of dihydronicotinate N-substitution on the brain-targeting efficacy of a zidovudine chemical delivery system.
    Brewster ME; Pop E; Braunstein AJ; Pop AC; Druzgala P; Dinculescu A; Anderson W; Elkoussi A; Bodor N
    Pharm Res; 1993 Sep; 10(9):1356-62. PubMed ID: 8234177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel approaches for designing 5'-O-ester prodrugs of 3'-azido-2', 3'-dideoxythymidine (AZT).
    Parang K; Wiebe LI; Knaus EE
    Curr Med Chem; 2000 Oct; 7(10):995-1039. PubMed ID: 10911016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative pharmacokinetics of two prodrugs of zidovudine in rabbits: enhanced levels of zidovudine in brain tissue.
    Lupia RH; Ferencz N; Lertora JJ; Aggarwal SK; George WJ; Agrawal KC
    Antimicrob Agents Chemother; 1993 Apr; 37(4):818-24. PubMed ID: 8494380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.